Outcomes after bone marrow versus peripheral blood haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis
Haploidentical HSCT recipients observed similar outcomes regardless of graft source. Marginally faster neutrophil engraftment was observed in PBSC recipients. These findings suggest flexibility in using graft source for haploidentical transplants, though prospective studies are needed to confirm these results.
Authors
- Muhammad Kashif Amin (ORCID: https://orcid.org/0000-0002-4052-7339)
- Iqra Anwar
- Al-Ola A. Abdallah (ORCID: https://orcid.org/0000-0002-6603-185X)
- Anurag K. Singh (ORCID: https://orcid.org/0000-0003-1114-9508)
- Muhammad Umair Mushtaq (ORCID: https://orcid.org/0000-0001-8122-0563)
- Ushna Khan
- Joseph P. McGuirk (ORCID: https://orcid.org/0000-0002-0539-4796)
- Matthew McGuirk
- Valiko Begiashvili (ORCID: https://orcid.org/0009-0003-0221-589X)
- Sunil Abhyankar (ORCID: https://orcid.org/0000-0002-8578-1226)
- Nausheen Ahmed (ORCID: https://orcid.org/0000-0003-4336-4982)
- Sibgha Gull Chaudhary
- Moazzam Shahzad (ORCID: https://orcid.org/0000-0002-9609-6160)
- Abat Khan
- Shaun DeJarnette
Institutions
- Moffitt Cancer Center (US)
- University of Kansas Medical Center (US)
- Cellular Therapeutics (United Kingdom) (GB)
Publication Details
- Journal
- Hematology Transfusion and Cell Therapy
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1016/j.htct.2025.106222
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00